{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:45:43Z","timestamp":1770511543276,"version":"3.49.0"},"reference-count":80,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R005850\/1"],"award-info":[{"award-number":["MR\/R005850\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["APQ-408675\/2018-7"],"award-info":[{"award-number":["APQ-408675\/2018-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Leishmaniases are neglected diseases caused by infection with Leishmania parasites and there are no human vaccines in use routinely. The purpose of this study was to examine the immunogenicity of ChimeraT, a novel synthetic recombinant vaccine against visceral leishmaniasis (VL), incorporated into a human-compatible liposome formulation. Methods: BALB\/c mice were immunized subcutaneously with ChimeraT\/liposome vaccine, ChimeraT\/saponin adjuvant, or ChimeraT\/saline and immune responses examined in vitro and in vivo. Results: Immunization with the ChimeraT\/liposome formulation induced a polarized Th1-type response and significant protection against L. infantum infection. ChimeraT\/liposome vaccine stimulated significantly high levels of interferon (IFN)-\u03b3, interleukin (IL)-12, and granulocyte macrophage-colony stimulating factor (GM-CSF) cytokines by both CD4 and CD8 T-cells, with correspondingly lower levels of IL-4 and IL-10 cytokines. Induced antibodies were predominantly IgG2a isotype, and homologous antigen-stimulated spleen cells produced significant nitrite as a proxy for nitric oxide (NO). Furthermore, we examined a small number of treated VL patients and found higher levels of circulating anti-ChimeraT protein IgG2 antibodies, compared to IgG1 levels. Conclusions: Overall, the liposomal formulation of ChimeraT induced a protective Th1-type immune response and thus could be considered in future studies as a vaccine candidate against human VL.<\/jats:p>","DOI":"10.3390\/vaccines8020289","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T05:16:14Z","timestamp":1591679774000},"page":"289","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis"],"prefix":"10.3390","volume":"8","author":[{"given":"Daniela P.","family":"Lage","sequence":"first","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia A.F.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Dias","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora V.C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7852-0300","authenticated-orcid":false,"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia M.","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunopatologia, N\u00facleo de Pesquisas em Ci\u00eancias Biol\u00f3gicas\/NUPEB, Departamento de Ci\u00eancias Biol\u00f3gicas, Insituto de Ci\u00eancias Exatas e Biol\u00f3gicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais 35400-000, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethina T.","family":"Steiner","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Instituto de Ci\u00eancias Biol\u00f3gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 31270-901, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda S.","family":"Machado","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-0457","authenticated-orcid":false,"given":"Tha\u00eds T.O.","family":"Santos","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7882-215X","authenticated-orcid":false,"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil S.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade, Universidade do Extremo Sul Catarinense, Crici\u00fama, Santa Catarina 88806-000, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5281-3263","authenticated-orcid":false,"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunopatologia, N\u00facleo de Pesquisas em Ci\u00eancias Biol\u00f3gicas\/NUPEB, Departamento de Ci\u00eancias Biol\u00f3gicas, Insituto de Ci\u00eancias Exatas e Biol\u00f3gicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais 35400-000, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1303-0490","authenticated-orcid":false,"given":"Ricardo A.","family":"Machado-de-\u00c1vila","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Instituto de Ci\u00eancias Biol\u00f3gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 31270-901, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-6981","authenticated-orcid":false,"given":"Maria V.","family":"Humbert","sequence":"additional","affiliation":[{"name":"Neisseria Research Group, Molecular Microbiology, School of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton SO16 6YD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[{"name":"Neisseria Research Group, Molecular Microbiology, School of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton SO16 6YD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-9014","authenticated-orcid":false,"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 30130-100, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"ref_1","unstructured":"World-Health-Organisation (2020, March 30). Available online: http:\/\/www.who.int\/topics\/leishmaniasis\/en\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: Current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chakravarty, J., Hasker, E., Kansal, S., Singh, O.P., Malaviya, P., Singh, A.K., Chourasia, A., Singh, T., Sudarshan, M., and Singh, A.P. (2019). Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007216"},{"key":"ref_4","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0031182017002116","article-title":"Chemotherapeutics of visceral leishmaniasis: Present and future developments","volume":"145","author":"Sundar","year":"2018","journal-title":"Parasitology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4269\/ajtmh.15-0033","article-title":"Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study","volume":"93","author":"Cunha","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.parint.2016.07.005","article-title":"Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system","volume":"65","author":"Duarte","year":"2016","journal-title":"Parasitol. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S0031182016002523","article-title":"Chemotherapy of leishmaniasis: Present challenges","volume":"145","author":"Uliana","year":"2018","journal-title":"Parasitology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.msec.2017.07.040","article-title":"Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment","volume":"81","author":"Garcia","year":"2017","journal-title":"Mat. Sci. Eng. C"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Palic, S., Bhairosing, P., Beijnen, J.H., and Dorlo, T.P.C. (2019). Systematic Review of Host-Mediated Activity of Miltefosine in Leishmaniasis through Immunomodulation. Antimicrob. Agents Chemother., 63.","DOI":"10.1128\/AAC.02507-18"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pijpers, J., den Boer, M.L., Essink, D.R., and Ritmeijer, K. (2019). The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia-A review and meta-analysis. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007173"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2018.09.029","article-title":"A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis","volume":"36","author":"Carnielli","year":"2018","journal-title":"Ebiomed"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/jac\/dkx407","article-title":"Miltefosine-resistant Leishmania infantum strains with an impaired MT\/ROS3 transporter complex retain amphotericin B susceptibility","volume":"73","author":"Mondelaers","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kedzierski, L., and Evans, K.J. (2014). Immune responses during cutaneous and visceral leishmaniasis. Parasitology, 1\u201319.","DOI":"10.1017\/S003118201400095X"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/cdli.2.3.291-296.1995","article-title":"Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis","volume":"2","author":"Ghosh","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/CDLI.6.2.231-235.1999","article-title":"Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients","volume":"6","author":"Anam","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1098-2825(2000)14:1<5::AID-JCLA2>3.0.CO;2-F","article-title":"Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis","volume":"14","author":"Dietze","year":"2000","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/JCM.40.3.1037-1043.2002","article-title":"Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis","volume":"40","author":"Ryan","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Caldas, A., Favali, C., Aquino, D., Vinhas, V., van Weyenbergh, J., Brodskyn, C., Costa, J., Barral-Netto, M., and Barral, A. (2005). Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: Implications in the pathogenesis. BMC Infect. Dis., 5.","DOI":"10.1186\/1471-2334-5-113"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.humimm.2009.01.007","article-title":"Th1\/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production","volume":"70","author":"Castellano","year":"2009","journal-title":"Hum. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/2051013617741578","article-title":"Liposomal adjuvant development for leishmaniasis vaccines","volume":"5","author":"Askarizadeh","year":"2017","journal-title":"Ther. Adv. Vaccines"},{"key":"ref_23","first-page":"15","article-title":"A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 against Experimental Infection with Leishmania infantum Scand","volume":"86","author":"Pirdel","year":"2017","journal-title":"J. Immunol."},{"key":"ref_24","first-page":"2558","article-title":"Immunization of Experimental Dogs With Salivary Proteins From Lutzomyia longipalpis, Using DNA and Recombinant Canarypox Virus Induces Immune Responses Consistent With Protection Against Leishmania infantum Front","volume":"9","author":"Abbehusen","year":"2018","journal-title":"Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.vaccine.2018.03.027","article-title":"Immunotherapeutic potential of Leishmania (Leishmania) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis","volume":"36","author":"Yadav","year":"2018","journal-title":"Vaccine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fimmu.2019.00288","article-title":"Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani","volume":"10","author":"Joshi","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.05.001","article-title":"Vaccination with a CD4(+) and CD8(+) T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis","volume":"200","author":"Dias","year":"2018","journal-title":"Transl. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Agallou, M., Margaroni, M., Athanasiou, E., Toubanaki, D.K., Kontonikola, K., Karidi, K., Kammona, O., Kiparissides, C., and Karagouni, E. (2017). Identification of BALB\/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005311"},{"key":"ref_29","first-page":"100","article-title":"A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection","volume":"8","author":"Nico","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Martins, V.T., Duarte, M.C., Lage, D.P., Costa, L.E., Carvalho, A.M., Mendes, T.A., Roatt, B.M., Menezes-Souza, D., Soto, M., and Coelho, E.A. (2017). A recombinant chimeric protein composed of human and mice-specific CD4(+) and CD8(+) T-cell epitopes protects against visceral leishmaniasis. Parasite Immunol., 39.","DOI":"10.1111\/pim.12359"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.apjtm.2015.06.008","article-title":"Immunogenicity and efficacy of recombinant 78 kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis","volume":"8","author":"Nagill","year":"2015","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2009.02.009","article-title":"The path to a successful vaccine adjuvant\u2014\u2018The long and winding road\u2019","volume":"14","year":"2009","journal-title":"Drug Discov. Today"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cyto.2018.08.019","article-title":"A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis","volume":"111","author":"Ribeiro","year":"2018","journal-title":"Cytokine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2019.04.092","article-title":"Visceral leishmaniasis: An overview of vaccine adjuvants and their applications","volume":"37","author":"Ratnapriya","year":"2019","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","article-title":"Adjuvant effects of saponins on animal immune responses","volume":"8","author":"Rajput","year":"2007","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/pim.12176","article-title":"Studies on cocktails of 31-kDa, 36-kDa and 51-kDa antigens of Leishmania donovani along with saponin against murine visceral leishmaniasis","volume":"37","author":"Kaur","year":"2015","journal-title":"Parasite Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.imbio.2015.05.014","article-title":"Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice","volume":"220","author":"Thakur","year":"2015","journal-title":"Immunobiology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.actatropica.2017.03.008","article-title":"Probing the efficacy of a heterologous Leishmania\/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB\/c mice","volume":"171","author":"Santos","year":"2017","journal-title":"Acta. Trop."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.micinf.2017.09.011","article-title":"Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis","volume":"20","author":"Das","year":"2018","journal-title":"Microbes Infect."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9124326","DOI":"10.1155\/2019\/9124326","article-title":"New Insights on the Adjuvant Properties of the Leishmania infantum Eukaryotic Initiation Factor","volume":"2019","author":"Koutsoni","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.intimp.2018.03.012","article-title":"Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle","volume":"59","author":"Noormehr","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"De Brito, R.C.F., Cardoso, J.M.O., Reis, L.E.S., Mathias, F.A.S., Aguiar-Soares, R.D.O., Teixeira-Carvalho, A., Roatt, B.M., Correa-Oliveira, R., Ruiz, J.C., and Resende, D.M. (2019). Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB\/c Mice. Vaccines, 7.","DOI":"10.3390\/vaccines7040162"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.vaccine.2012.11.068","article-title":"Micro\/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends","volume":"31","author":"Badiee","year":"2013","journal-title":"Vaccine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.2147\/IJN.S207589","article-title":"Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages","volume":"14","author":"Ye","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ramakrishnan, A., Schumack, N.M., Gariepy, C.L., Eggleston, H., Nunez, G., Espinoza, N., Nieto, M., Castillo, R., Rojas, J., and McCoy, A.J. (2019). Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21. mSphere, 4.","DOI":"10.1128\/mSphere.00440-19"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/infdis\/jiy348","article-title":"Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans","volume":"218","author":"Rao","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1462-5822.2009.01406.x","article-title":"Leishmania cell surface prohibitin: Role in host-parasite interaction","volume":"12","author":"Jain","year":"2010","journal-title":"Cell Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/CVI.00465-15","article-title":"Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis","volume":"22","author":"Duarte","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molimm.2016.06.014","article-title":"A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection","volume":"76","author":"Duarte","year":"2016","journal-title":"Mol. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2017.11.001","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"323","author":"Dias","year":"2018","journal-title":"Cell Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1017\/S0031182019000714","article-title":"Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach","volume":"146","author":"Lage","year":"2019","journal-title":"Parasitology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cellimm.2016.12.008","article-title":"A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection","volume":"313","author":"Martins","year":"2017","journal-title":"Cell Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-60327-118-9_13","article-title":"Prediction of peptide-MHC binding using profiles","volume":"409","author":"Reche","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: The proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Gasteiger","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1590\/0037-8682-0120-2016","article-title":"Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis","volume":"49","author":"Duarte","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2018.08.004","article-title":"Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides","volume":"103","author":"Agallou","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Gomes, R.S., Silva, M.V.T., dos Santos, J.C., van Linge, C., Reis, J.M., Teixeira, M.M., Pinto, S.A., Dorta, M.L., Bai, X.Y., and Chan, E.D. (2018). Human Interleukin-32 gamma Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice. Infect. Immun., 86.","DOI":"10.1128\/IAI.00796-17"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Sabur, A., Bhowmick, S., Chhajer, R., Ejazi, S.A., Didwania, N., Asad, M., Bhattacharyya, A., Sinha, U., and Ali, N. (2018). Liposomal Elongation Factor-1 alpha Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00018"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Costa, L.E., Alves, P.T., Carneiro, A.P., Dias, A.C.S., Fujimura, P.T., Araujo, G.R., Tavares, G.S.V., Ramos, F.F., Duarte, M.C., and Menezes-Souza, D. (2019). Leishmania infantum-Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081812"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.diagmicrobio.2019.04.015","article-title":"Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls","volume":"95","author":"Vale","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ribeiro, P.A.F., Vale, D.L., Dias, D.S., Lage, D.P., Mendonca, D.V.C., Ramos, F.F., Carvalho, L.M., Carvalho, A., Steiner, B.T., and Roque, M.C. (2020). Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis. Cytokine, 129.","DOI":"10.1016\/j.cyto.2020.155031"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/IAI.66.1.18-27.1998","article-title":"Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani","volume":"66","author":"Melby","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5699(99)01549-2","article-title":"Organ-specific immune responses associated with infectious disease","volume":"21","author":"Engwerda","year":"2000","journal-title":"Immunol. Today"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carrion","year":"2006","journal-title":"Parasite Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.pt.2015.08.001","article-title":"Induction, Propagation, and Activity of Host Nitric Oxide: Lessons from Leishmania Infection","volume":"31","author":"Olekhnovitch","year":"2015","journal-title":"Trends Parasitol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425247.2011.558081","article-title":"Liposomal vaccine delivery systems","volume":"8","author":"Korsholm","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.exppara.2012.09.001","article-title":"The role of liposome size on the type of immune response induced in BALB\/c mice against leishmaniasis: rgp63 as a model antigen","volume":"132","author":"Badiee","year":"2012","journal-title":"Exp. Parasitol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Singh, O.P., Stober, C.B., Singh, A.K., Blackwell, J.M., and Sundar, S. (2012). Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001874"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.imbio.2017.10.043","article-title":"Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis","volume":"223","author":"Portela","year":"2018","journal-title":"Immunobiology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Martins, V.T., Duarte, M.C., Chavez-Fumagalli, M.A., Menezes-Souza, D., Coelho, C.S.P., de Magalhaes-Soares, D.F., Fernandes, A.P., Soto, M., Tavares, C.A.P., and Coelho, E.A.F. (2015). A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis. Parasites Vectors, 8.","DOI":"10.1186\/s13071-015-0964-5"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.actatropica.2015.11.006","article-title":"A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis","volume":"154","author":"Martins","year":"2016","journal-title":"Acta Trop."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1017\/S0031182017001731","article-title":"Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis","volume":"145","author":"Dias","year":"2018","journal-title":"Parasitology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molimm.2018.12.025","article-title":"Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection","volume":"106","author":"Ribeiro","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Saljoughian, N., Taheri, T., Zahedifard, F., Taslimi, Y., Doustdari, F., Bolhassani, A., Doroud, D., Azizi, H., Heidari, K., and Vasei, M. (2013). Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae. Vaccine against Experimental Murine Visceral Leishmaniasis. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002174"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/pim.12356","article-title":"Evaluation of a novel lentiviral vaccine expressing KMP11-HASPB fusion protein against Leishmania infantum in BALB\/c mice","volume":"38","author":"Mortazavidehkordi","year":"2016","journal-title":"Parasite Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/jbm.b.33965","article-title":"3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine","volume":"106","author":"Wang","year":"2018","journal-title":"J. Biomed. Mat. Res. Part B"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molbiopara.2012.02.009","article-title":"In silico identification of conserved intercoding sequences in Leishmania genomes: Unraveling putative cis-regulatory elements","volume":"183","author":"Vasconcelos","year":"2012","journal-title":"Mol. Biochem. Parasitol"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/2\/289\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:36:57Z","timestamp":1760175417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/2\/289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":80,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["vaccines8020289"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8020289","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]}}}